Literature DB >> 30114641

Postmenopausal osteoporosis and breast cancer: The biochemical links and beneficial effects of functional foods.

Aliyu Muhammad1, Sanusi Bello Mada2, Ibrahim Malami3, Gilead E Forcados2, Ochuko L Erukainure4, Hadiza Sani5, Ibrahim Babangida Abubakar6.   

Abstract

Breast cancer as a multifactorial disease has been classified among the major causes of morbidity and mortality in women across the world, with a higher prevalence among post-menopausal women. Osteoporosis, a condition characterized by altered bone mineralization is also commonly found among post-menopausal women. Consequently, post-menopausal women are at risk of morbidity and mortality associated with breast cancer and postmenopausal osteoporosis. This may not be unconnected to the fact that, there may be existent biochemical links between the two mayhems, which might rally round between the cellular and molecular connectivity based on the actions and inactions of RANKL, estrogen, free radicals-induced oxidative stress and metabolic implications of age related obesity among others. Cells and tissues including breast and bone are more prone to oxidative stress with age, and oxidative stress could alter the activity of key proteins and pathways required for protection against breast cancer and osteoporosis. As a result, the potentials of antioxidant rich functional foods in preventing, managing and possibly treating breast cancer and postmenopausal osteoporosis cannot be overemphasised. This review mainly uses ISI, SCOPUS and PubMed indexed journals and books containing various experimental reports vacillating from humans, animals and in vitro studies in relation to breast cancer and postmenopausal osteoporosis, biochemical links and possible beneficial effects of functional foods. One distinct feature of the review is that it categorically intends to provide a critical appraisal on the said available experimental data within the variables of breast cancer and osteoporosis among females vis-à-vis the potentials of functional foods.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Breast cancer; Effects; Functional foods; Links; Osteoporosis; Postmenopausal

Mesh:

Year:  2018        PMID: 30114641     DOI: 10.1016/j.biopha.2018.08.018

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

Review 1.  Update on the Role of Neuropeptide Y and Other Related Factors in Breast Cancer and Osteoporosis.

Authors:  Shu-Ting Lin; Yi-Zhong Li; Xiao-Qi Sun; Qian-Qian Chen; Shun-Fa Huang; Shu Lin; Si-Qing Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-06       Impact factor: 5.555

Review 2.  New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach.

Authors:  Magdalena Woźniczka; Katarzyna Błaszczak-Świątkiewicz
Journal:  Molecules       Date:  2021-10-27       Impact factor: 4.411

3.  Analysis of the Occurrence of Diseases Following Gastrectomy for Early Gastric Cancer: a Nationwide Claims Study.

Authors:  Ho Seok Seo; Yewon Na; Jaehun Jung
Journal:  J Gastric Cancer       Date:  2021-10-01       Impact factor: 3.720

Review 4.  Therapeutic Treatments for Osteoporosis-Which Combination of Pills Is the Best among the Bad?

Authors:  Christian Horst Tonk; Sarah Hani Shoushrah; Patrick Babczyk; Basma El Khaldi-Hansen; Margit Schulze; Monika Herten; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

5.  Cicer arietinum L. Sprouts' Influence on Mineralization of Saos-2 and Migration of MCF-7 Cells.

Authors:  Małgorzata Zakłos-Szyda; Ilona Gałązka-Czarnecka; Joanna Grzelczyk; Grażyna Budryn
Journal:  Molecules       Date:  2020-09-30       Impact factor: 4.411

Review 6.  The Improving Effect and Safety of Probiotic Supplements on Patients with Osteoporosis and Osteopenia: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.

Authors:  Liuting Zeng; Ganpeng Yu; Kailin Yang; Wensa Hao; Hua Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-24       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.